Trial Details
COMPLETEDBasic Information
| Clinical ID | c3167 |
|---|---|
| Identifier | NCT02437591 |
| Trial Title | Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease (IBD)|Clostridium Difficile Infection (CDI) |
| Interventions | DRUG: fidaxomicin |
Participant Information
| Sponsor | Astellas Pharma Europe Ltd. |
|---|---|
| City | Graz |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2015-08-13 |
|---|---|
| Primary Completion Date | 2016-05-12 |
| Completion Date | 2016-10-24 |